Imaging glutamate in schizophrenia: review of findings and implications for drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

Published:2013-10-29 Issue:1 Volume:19 Page:20-29
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Poels E M P,Kegeles L S,Kantrowitz J T,Slifstein M,Javitt D C,Lieberman J A,Abi-Dargham A,Girgis R R

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

http://www.nature.com/articles/mp2013136.pdf

Reference138 articles.

1. Miyamoto S, Miyake N, Jarskog LF, Fleischhacker WW, Lieberman JA . Pharmacological treatment of schizophrenia: an update and critical review of the pharmacology and clinical profiles of current and future therapeutic agents. Mol Psychiatry 2012; 17: 1206–1227.

2. Miyamoto S, Duncan GE, Marx CE, Lieberman JA . Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 2005; 10: 79–104.

3. Baker DA, Madayag A, Kristiansen LV, Meador-Woodruff JH, Haroutunian V, Raju I . Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine. Neuropsychopharmacology 2008; 33: 1760–1772.

4. Kantrowitz JT, Javitt DC . N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 2010; 83: 108–121.

5. Singh SP, Singh V . Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs 2011; 25: 859–868.

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia;Biochemical Pharmacology;2024-05

2. New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists;Neuropsychiatric Disease and Treatment;2024-03

3. Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls;International Journal of Neuropsychopharmacology;2024-02-19

4. Schizophrenia: from neurochemistry to circuits, symptoms and treatments;Nature Reviews Neurology;2023-12-18

5. Phase 2 Results Indicate Evenamide, A Selective Modulator of Glutamate Release, Is Associated With Clinically Important Long-Term Efficacy When Added to an Antipsychotic in Patients With Treatment-Resistant Schizophrenia;International Journal of Neuropsychopharmacology;2023-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3